Stocks
Corcept Therapeutics Incorporated (CORT) EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 128.2 | 130.4 | 124.5 | 112.6 | 108.3 | 144.6 | ||
| Changes by years, y/y, % | +13% | +2% | -5% | -10% | -4% | +3.9% | |||
Corcept Therapeutics Incorporated. EBITDA US GAAP, bln rub
Corcept Therapeutics Incorporated. EBITDA US GAAP, changes, %
Corcept Therapeutics Incorporated. EBITDA US GAAP, sum by quarters, bln rub
Corcept Therapeutics Incorporated (CORT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 31.2 | 32.2 | 29.6 | 35.6 | 47.1 | 144.6 | |
| Changes by years, y/y, % | -5% | +43% | +99% | +17% | +51% | |||
| Changes by quarters, q/q, % | +3% | +3% | -8% | +20% | +32% | |||
